Tekla Life Sciences Investors Asset Resilience Ratio
Tekla Life Sciences Investors asset resilience ratio. Tekla Life Sciences Investors (HQL) has an Asset Resilience Ratio of 0.15% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Tekla Life Sciences Investors to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Tekla Life Sciences Investors (2016–2024)
Asset resilience ratio of Tekla Life Sciences Investors from 2016 to 2024. This chart shows how Tekla Life Sciences Investors's Asset Resilience Ratio has changed over time. Read Tekla Life Sciences Investors total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Tekla Life Sciences Investors's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see HQL current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $851.60K | 0.15% |
| Total Liquid Assets | $851.60K | 0.15% |
Asset Resilience Insights
- Limited Liquidity: Tekla Life Sciences Investors maintains only 0.15% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tekla Life Sciences Investors Industry Peers by Asset Resilience Ratio
Compare Tekla Life Sciences Investors's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sprott Physical Silver
TO:PSLV |
Asset Management | 99.90% |
|
Argo Investments Ltd
AU:ARG |
Asset Management | 0.46% |
|
Anxin Trust Co Ltd
SHG:600816 |
Asset Management | 36.21% |
|
KBC Ancora
BR:KBCA |
Asset Management | 1.63% |
|
Sprott Inc.
TO:SII |
Asset Management | 1.84% |
|
Investco Holding AS
IS:INVES |
Asset Management | 11.35% |
|
L1 Group Limited
AU:L1G |
Asset Management | 21.83% |
|
Pinnacle Investment Management Group Ltd
AU:PNI |
Asset Management | 12.36% |
Tekla Life Sciences Investors Asset Resilience Ratio by Year (2016–2024)
Tekla Life Sciences Investors asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Tekla Life Sciences Investors.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-09-30 | 3.74% | $17.23 Million | $460.58 Million | -0.04pp |
| 2023-09-30 | 3.79% | $15.24 Million | $402.60 Million | -4.16pp |
| 2022-09-30 | 7.94% | $32.94 Million | $414.73 Million | +4.73pp |
| 2021-09-30 | 3.21% | $17.17 Million | $534.19 Million | +2.19pp |
| 2020-09-30 | 1.03% | $4.97 Million | $484.17 Million | -2.08pp |
| 2019-09-30 | 3.11% | $12.03 Million | $386.98 Million | +3.11pp |
| 2018-09-30 | 0.00% | $-1.00 | $478.47 Million | 0.00pp |
| 2017-09-30 | 0.00% | $4.00 | $468.33 Million | -2.36pp |
| 2016-09-30 | 2.36% | $9.85 Million | $417.63 Million | -- |
About Tekla Life Sciences Investors
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, … Read more